Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model
出版年份 2022 全文链接
标题
Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-03
DOI
10.1038/s41598-022-06953-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A humanized CD3ε-knock-in mouse model for pre-clinical testing of anti-human CD3 therapy
- (2021) Joel Crespo et al. PLoS One
- Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy
- (2021) G. Fucà et al. ESMO Open
- Modeling the Dynamics of T-Cell Development in the Thymus
- (2021) Philippe A. Robert et al. Entropy
- Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
- (2021) Brian Belmontes et al. Science Translational Medicine
- Perspective: Designing T-Cell Engagers With Better Therapeutic Windows
- (2020) Omid Vafa et al. Frontiers in Oncology
- Integrated Approach for Characterizing Bispecific Antibody/Antigens Complexes and Mapping Binding Epitopes with SEC/MALS, Native Mass Spectrometry, and Protein Footprinting
- (2020) Richard Y.-C. Huang et al. ANALYTICAL CHEMISTRY
- Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
- (2019) Nathan D. Trinklein et al. mAbs
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology
- (2019) Ryoichi Saito et al. International Journal of Clinical Oncology
- Structural basis of assembly of the human T cell receptor–CD3 complex
- (2019) De Dong et al. NATURE
- Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models
- (2019) Feng Wang et al. mAbs
- Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
- (2018) Diego Ellerman METHODS
- CD3-bispecific antibody therapy turns solid tumors into inflammatory sites but does not install protective memory
- (2018) Hreinn Benonisson et al. MOLECULAR CANCER THERAPEUTICS
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
- (2017) Aran F. Labrijn et al. Scientific Reports
- Entire CD3ε, δ and γ humanized mouse to evaluate human CD3–mediated therapeutics
- (2017) Otoya Ueda et al. Scientific Reports
- Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping
- (2014) Paula J P de Vree et al. NATURE BIOTECHNOLOGY
- T Cell Receptors are Structures Capable of Initiating Signaling in the Absence of Large Conformational Rearrangements
- (2012) Ricardo A. Fernandes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now